Skip to main content

Good Laboratory Practice (GLP) Requirements for Preclinical Animal Studies

  • Chapter
  • First Online:
Essentials of Laboratory Animal Science: Principles and Practices

Abstract

There are persistent efforts to discover newer drugs to address huge unmet needs in the treatment of various disease conditions. The process of drug discovery and development involves both the preclinical and clinical studies which are very challenging and have huge commercial interests. Following the scientific malpractice in the pharmaceutical industries and contract research laboratories in the USA, the “good laboratory practice (GLP)” regulations were enforced in the arena of preclinical drug testing in the late 1970s. In 1981, the Organization for Economic Cooperation and Development (OECD) also developed its GLP principles which are internationally accepted. Given the public health and environmental safety concerns, various regulations and guidelines emphasize the compliance for GLP in the preclinical or nonclinical health and environmental safety studies. GLP assures the regulatory authority that the nonclinical safety data they receive from the sponsors are of high quality and accuracy that can be relied on in the risk assessment process for the product registration. The accreditation and compliance for GLP are voluntary for the test facilities and are required in the case of the regulatory submission. The present chapter covers the overview of the principles of GLP with the primary focus on requirements related to the test system in preclinical animal studies during the new drug development.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sinha S, Vohora D (2018) Drug discovery and development: an overview. In: Pharmaceutical medicine and translational clinical Research. Academic Press, Boston, pp 19–32

    Chapter  Google Scholar 

  2. Gad SC (ed) (2001) Regulatory toxicology. CRC Press, Boca Raton, FL

    Google Scholar 

  3. Kille JW (2017) Regulatory toxicology. In: A comprehensive guide to toxicology in nonclinical drug development. Academic Press, Cambridge, pp 499–539

    Chapter  Google Scholar 

  4. Gad SC (ed) (2006) Animal models in toxicology. CRC Press, Boca Raton

    Google Scholar 

  5. Saganuwan SA (2017) Toxicity studies of drugs and chemicals in animals: an overview. Bulg J Vet Med 20(4):291–318

    Article  Google Scholar 

  6. Colerangle JB (2017) Preclinical development of non oncogenic drugs (small and large molecules). In: A comprehensive guide to toxicology in nonclinical drug development. Academic Press, Cambridge, pp 659–683

    Chapter  Google Scholar 

  7. Dorato MA, Buckley LA (2007) Toxicology testing in drug discovery and development. Curr Protoc Toxicol 31(1):19–11

    Article  Google Scholar 

  8. OECD (1998) OECD Principles of good laboratory practice (as revised in 1997)

    Google Scholar 

  9. Bode G (2018) Regulatory guidance: ICH, EMA, FDA. In book: Drug discovery and evaluation: methods in clinical pharmacology:1–54

    Google Scholar 

  10. New Drugs and Clinical Trials Rules (2019). https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/NewDrugs_CTRules_2019.pdf

  11. Food and Drug Administration (2004). Comparison chart of FDA and EPA Good Laboratory Practice (GLP) regulations and the OECD principles of GLP. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/fda-bioresearch-monitoring-information/comparison-chart-fda-and-epa-good-laboratory-practice-glp-regulations-and-oecd-principles-glp

  12. ICH M3(R2) (2009) Guidance on nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals M3 (R2). In: International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use

    Google Scholar 

  13. Cwiertniewicz J (2005) Introduction to the good laboratory practice regulations. Lab Anim 34(3):29–32

    Article  Google Scholar 

  14. ECHA. REACH tests need to comply with good laboratory practice. https://echa.europa.eu/-/reach-tests-need-to-comply-with-good-laboratory-practice

  15. Gad SC (2016) Drug safety evaluation. Wiley, New York, NY

    Book  Google Scholar 

  16. Chorghade MS (ed) (2007) Drug discovery and development, Volume 2: Drug development, Wiley

    Google Scholar 

  17. Takenaka T (2001) Classical vs reverse pharmacology in drug discovery. BJU Int 88:7–10

    Article  CAS  Google Scholar 

  18. Hughes JP, Rees S, Kalindjian SB, Philpott KL (2011) Principles of early drug discovery. Br J Pharmacol 162(6):1239–1249

    Article  CAS  Google Scholar 

  19. Russell C, Rahman A, Mohammed AR (2013) Application of genomics, proteomics and metabolomics in drug discovery, development and clinic. Ther Deliv 4(3):395–413

    Article  CAS  Google Scholar 

  20. Andrade EL, Bento AF, Cavalli J, Oliveira SK, Schwanke RC, Siqueira JM et al (2016) Non-clinical studies in the process of new drug development-Part II: Good laboratory practice, metabolism, pharmacokinetics, safety and dose translation to clinical studies. Braz J Med Biol Res 49(12):e5646

    Article  CAS  Google Scholar 

  21. Sahota PS, Popp JA, Hardisty JF, Gopinath C (eds) (2013) Toxicologic pathology: nonclinical safety assessment. CRC Press, Boca Raton, FL

    Google Scholar 

  22. Food and Drug Administration. A history of the FDA and drug regulation in the United States. https://www.fda.gov/media/73549/download

  23. Rahalkar H (2012) Historical overview of pharmaceutical industry and drug regulatory affairs. Pharmaceut Reg Aff S11:002

    Google Scholar 

  24. Vargesson N (2015) Thalidomide-induced teratogenesis: History and mechanisms. Birth Defects Res C Embryo Today 105(2):140–156

    Article  CAS  Google Scholar 

  25. Kelsey FO (1988) Thalidomide update: regulatory aspects. Teratology 38(3):221–226

    Article  CAS  Google Scholar 

  26. Schneider K (1983) Faking it. The Case against Industrial Bio-Test Laboratories. Amic J 4:14–26

    Google Scholar 

  27. Baldeshwiler AM (2003) History of FDA good laboratory practices. Qual Assur J 7(3):157–161

    Article  Google Scholar 

  28. Weinberg S (ed) (2007) Good laboratory practice regulations. CRC Press

    Google Scholar 

  29. FDA. Good laboratory practices for nonclinical laboratory studies. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=58&showFR=1

  30. Seiler JP (2005) Good laboratory practice: the why and the how. Springer Science & Business Media

    Google Scholar 

  31. OECD (1981) Decision of the Council concerning the Mutual Acceptance of Data in the Assessment of Chemicals. [C(81)30]

    Google Scholar 

  32. OECD (1997) OECD Series on Principles of Good Laboratory Practice and Compliance Monitoring. https://www.oecd-ilibrary.org/environment/oecd-series-on-principles-of-good-laboratory-practice-and-compliance-monitoring_2077785x

  33. OECD (1994) OECD Guidelines for the Testing of Chemicals. https://www.oecd.org/chemicalsafety/testing/oecdguidelinesforthetestingofchemicals.htm

  34. OECD (1997) Decision of Council Concerning the Adherence of non-Member countries to the Council Acts related to the Mutual Acceptance of Data in the Assessment of Chemicals. [C(97)114]

    Google Scholar 

  35. NGCMA. https://dst.gov.in/ngcma

  36. EMA (European Medicines Agency) Good laboratory practice compliance. https://www.ema.europa.eu/en/human-regulatory/research-development/compliance/good-laboratory-practice-compliance

  37. Jawahar N, Lakshmi VT (2017) Regulatory requirements for the drug approval process in US, Europe and India. J Pharm Sci Res 9(10):1943–1952

    Google Scholar 

  38. Guidance document on toxicology for registration of Chemical pesticides in India, September 2017., http://ppqs.gov.in/sites/default/files/toxguidancedocsept2017.pdf

  39. PMDA (Pharmaceuticals and Medical Devices Agency) Ministerial ordinance on Good Laboratory Practice for nonclinical safety studies of drugs. https://www.pmda.go.jp/files/000153713.pdf

  40. Turnheim D (1993) Benefits of good laboratory practice as a tool to improve testing. Hum Exp Toxicol 12(6):528–532

    Article  CAS  Google Scholar 

  41. Hickman S, Ogilvie B, Patterson T (2018) To GLP or not to GLP? Drug Discov 19:61

    Google Scholar 

  42. Carson, P. A., Dent, N. J. (Eds.). (2007) Good clinical, laboratory and manufacturing practices: techniques for the QA professional. Royal Society of Chemistry

    Google Scholar 

  43. OECD Document No. 21 (2020) OECD Position Paper Regarding Possible Influence of Sponsors on Conclusions of GLP Studies

    Google Scholar 

  44. OECD Document No. 8 (1999) The Role and Responsibilities of the Study Director in GLP Studies

    Google Scholar 

  45. OECD Document No. 13 (2002) The Application of the OECD Principles of GLP to the Organisation and Management of Multi-Site Studies

    Google Scholar 

  46. OECD.Document No. 19 (2018) Advisory document of the working group on good laboratory practice on the management, Characterisation and use of test items

    Google Scholar 

  47. OECD Document No. 4 (1999) Quality Assurance and GLP

    Google Scholar 

  48. World Health Organization (2010) Handbook: good laboratory practice (GLP): quality practices for regulated non-clinical research and development. World Health Organization

    Google Scholar 

  49. Stiles T (1997) The revised OECD principles of good laboratory practice. a reflection upon the impact of the proposed changes on pre-clinical safety testing: Part 1: Scope, definition of terms, responsibilities. Qual Assurance J Qual Assurance J Pharmaceut Health Environ Prof 2(1):13–18

    Google Scholar 

  50. Heinz-Taheny K (2013) Pathology and GLPs, quality control and quality assurance. In: Haschek and Rousseaux's Handbook of toxicologic pathology. Academic Press, pp 519–536

    Google Scholar 

  51. Boverhof DR, Chamberlain MP, Elcombe CR, Gonzalez FJ, Heflich RH, Hernandez LG et al (2011) Transgenic animal models in toxicology: historical perspectives and future outlook. Toxicol Sci 121(2):207–233

    Article  CAS  Google Scholar 

  52. Nohmi T, Masumura K, Toyoda-Hokaiwado N (2017) Transgenic rat models for mutagenesis and carcinogenesis. Genes Environ 39(1):1–32

    Article  Google Scholar 

  53. CPCSEA. CPCSEA guidelines for laboratory animal facility, India http://cpcsea.nic.in/WriteReadData/userfiles/file/SOP_CPCSEA_inner_page.pdf

  54. National Research Council (US) (2011) Guide for the care and use of laboratory animals, 8th edn. National Academies Press (US), Washington, DC

    Google Scholar 

  55. Canadian Council on Animal Care (2003) Guidelines on: laboratory animal facilities — characteristics, design and development. (as revised 2020) https://www.ccac.ca/Documents/Standards/Guidelines/Facilities.pdf,

  56. Deshmukh P (2018) Animal research facility for conducting GLP study. MOJ Toxicol 4(3):205–207

    Article  Google Scholar 

  57. European Commission Guidance Document for GLP inspectors and GLP Test Facilities (2004) Cross-contamination of control samples with test item in animal studies

    Google Scholar 

  58. OECD (2008) Repeated Dose 28-day Oral Toxicity Study in Rodents. OECD Guidelines for the Testing of Chemicals. Section 4: Health Effects

    Google Scholar 

  59. Prichett-Corning, K. R., Shek, W. R., Henderson, K. S., Clifford, C. B. (2009) Companion guide to rodent health surveillance for research facilities (No. 636.02 COM)

    Google Scholar 

  60. World Health Organization (2010) Good laboratory practice training manual: for the trainee: a tool for training and promoting Good Laboratory Practice (GLP) Concepts in Disease Endemic Countries. World Health Organization

    Google Scholar 

  61. OECD Document No. 5 (1999) Compliance of Laboratory Suppliers with GLP Principles

    Google Scholar 

  62. OECD Document No. 14 (2004) The Application of the Principles of GLP to in vitro studies

    Google Scholar 

  63. Borgert CJ, Becker RA, Carlton BD, Hanson M, Kwiatkowski PL, Sue Marty M, Witorsch RJ (2016) Does GLP enhance the quality of toxicological evidence for regulatory decisions? Toxicol Sci 151(2):206–213

    Article  CAS  Google Scholar 

  64. Wallace JM, Trundy RL (2018) Animal research pathology: regulatory and safety considerations. ILAR J 59(1):111–118

    Article  CAS  Google Scholar 

  65. OECD Document No 16 (2014) Guidance on the GLP Requirements for Peer Review of Histopathology

    Google Scholar 

  66. Seaton M (2014) The study pathologist’s role in GLP studies: a regulator’s perspective. Toxicol Pathol 42(1):285–285

    Article  Google Scholar 

  67. Becker RA, Janus ER, White RD, Kruszewski FH, Brackett RE (2009) Good laboratory practices and safety assessments. Environ Health Perspect 117(11):A482–A483

    Article  Google Scholar 

  68. OECD document No. 18 (2016) OECD Position Paper Regarding the Relationship between the OECD Principles of GLP and ISO/IEC 17025

    Google Scholar 

  69. OECD Harmonised Templates for reporting chemical test summaries. http://www.oecd.org/ehs/templates/

  70. Bolon B, Baze W, Shilling CJ, Keatley KL, Patrick DJ, Schafer KA (2018) Good laboratory practice in the academic setting: fundamental principles for nonclinical safety assessment and GLP-compliant pathology support when developing innovative biomedical products. ILAR J 59(1):18–28

    Article  CAS  Google Scholar 

  71. Jena GB, Chavan S (2017) Implementation of Good Laboratory Practices (GLP) in basic scientific research: translating the concept beyond regulatory compliance. Regul Toxicol Pharmacol 89:20–25

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K. Srinivasan .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Srinivasan, K., Tikoo, K., Jena, G.B. (2021). Good Laboratory Practice (GLP) Requirements for Preclinical Animal Studies. In: Nagarajan, P., Gudde, R., Srinivasan, R. (eds) Essentials of Laboratory Animal Science: Principles and Practices. Springer, Singapore. https://doi.org/10.1007/978-981-16-0987-9_27

Download citation

Publish with us

Policies and ethics